The Alzheimer’s Clinical Trial Learning Community Advisory Board Executive Report highlights key challenges and solutions in clinical trial participation, emphasizing the need for culturally competent outreach and increased caregiver support. It also provides actionable recommendations to address healthcare disparities, improve trust in research, and enhance patient access to Alzheimer’s clinical trials.

View the report.